atai Life Sciences (ATAI) Competitors

ADMA Biologics (NASDAQ:ADMA) and atai Life Sciences (NASDAQ:ATAI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Is ADMA or ATAI more profitable?

ADMA Biologics has a net margin of 44.06% compared to atai Life Sciences' net margin of 0.00%. ADMA Biologics' return on equity of 41.01% beat atai Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ADMA Biologics	44.06%	41.01%	28.47%
atai Life Sciences	N/A	-85.43%	-64.38%

Does the media favor ADMA or ATAI?

In the previous week, ADMA Biologics had 8 more articles in the media than atai Life Sciences. MarketBeat recorded 9 mentions for ADMA Biologics and 1 mentions for atai Life Sciences. ADMA Biologics' average media sentiment score of 1.75 beat atai Life Sciences' score of 0.73 indicating that ADMA Biologics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ADMA Biologics	9 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
atai Life Sciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, ADMA or ATAI?

ADMA Biologics has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, atai Life Sciences has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.

Which has preferable earnings and valuation, ADMA or ATAI?

ADMA Biologics has higher revenue and earnings than atai Life Sciences. atai Life Sciences is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADMA Biologics	$426.45M	9.46	$197.67M	$0.86	19.66
atai Life Sciences	$310K	3,152.87	-$149.27M	-$0.69	-6.61

Do institutionals & insiders have more ownership in ADMA or ATAI?

75.7% of ADMA Biologics shares are owned by institutional investors. Comparatively, 28.4% of atai Life Sciences shares are owned by institutional investors. 3.5% of ADMA Biologics shares are owned by company insiders. Comparatively, 26.8% of atai Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts recommend ADMA or ATAI?

ADMA Biologics currently has a consensus price target of $27.67, suggesting a potential upside of 63.61%. atai Life Sciences has a consensus price target of $11.25, suggesting a potential upside of 146.71%. Given atai Life Sciences' higher probable upside, analysts clearly believe atai Life Sciences is more favorable than ADMA Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADMA Biologics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
atai Life Sciences	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.17

Summary

ADMA Biologics beats atai Life Sciences on 11 of the 17 factors compared between the two stocks.